BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15547745)

  • 1. mRNA and protein expression of PUMA in sporadic colorectal cancer.
    Jansson A; Arbman G; Sun XF
    Oncol Rep; 2004 Dec; 12(6):1245-9. PubMed ID: 15547745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noxa in colorectal cancer: a study on DNA, mRNA and protein expression.
    Jansson AK; Emterling AM; Arbman G; Sun XF
    Oncogene; 2003 Jul; 22(30):4675-8. PubMed ID: 12879012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
    Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
    Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer.
    Middelburg R; de Haas RR; Dekker H; Kerkhoven RM; Pohlmann PR; Fuentes-Alburo A; Mohar A; Pinedo HM; Lankelma J
    Clin Cancer Res; 2005 Mar; 11(5):1863-9. PubMed ID: 15756011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha induces p53 up-regulated modulator of apoptosis expression in colorectal cancer cell lines.
    Pastor DM; Irby RB; Poritz LS
    Dis Colon Rectum; 2010 Mar; 53(3):257-63. PubMed ID: 20173470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUMA expression is significantly reduced in human cutaneous melanomas.
    Karst AM; Dai DL; Martinka M; Li G
    Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
    Han HS; Park YM; Hwang TS
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells.
    Gessi S; Cattabriga E; Avitabile A; Gafa' R; Lanza G; Cavazzini L; Bianchi N; Gambari R; Feo C; Liboni A; Gullini S; Leung E; Mac-Lennan S; Borea PA
    Clin Cancer Res; 2004 Sep; 10(17):5895-901. PubMed ID: 15355922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells.
    Liu Z; Lu H; Shi H; Du Y; Yu J; Gu S; Chen X; Liu KJ; Hu CA
    Cancer Res; 2005 Mar; 65(5):1647-54. PubMed ID: 15753358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y
    Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas.
    Yoo NJ; Lee JW; Jeong EG; Lee SH
    Dig Liver Dis; 2007 Mar; 39(3):222-7. PubMed ID: 17267315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells.
    Wang X; Wang J; Lin S; Geng Y; Wang J; Jiang B
    J Exp Clin Cancer Res; 2008 Sep; 27(1):44. PubMed ID: 18811981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes.
    Kalousek I; Brodska B; Otevrelova P; Röselova P
    Anticancer Drugs; 2007 Aug; 18(7):763-72. PubMed ID: 17581298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
    Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
    Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF-2 is downregulated in tumor tissue compared with normal mucosa.
    Sundlisaeter E; Røsland GV; Hertel JK; Sakariassen PØ; Almås B; Dicko A; Søndenaa K
    APMIS; 2009 Mar; 117(3):212-21. PubMed ID: 19245594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.